StonvexLoading…
StonvexStonvexStonvexCore line items from LSAK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $659.70M | $564.22M | $527.97M | $222.61M |
Operating Income | $-27.10M | $3.59M | $-15.35M | $-40.20M |
Net Income | $-87.50M | $-17.44M | $-35.07M | $-43.88M |
EPS (Diluted) | $-1.14 | $-0.27 | $-0.56 | $-0.75 |
Total Assets | $653.71M | $558.45M | $542.23M | $656.57M |
Total Liabilities | $392.33M | $303.16M | $283.33M | $342.22M |
Cash & Equivalents | $76.52M | $59.06M | $35.50M | $43.94M |
Free Cash Flow OCF − CapEx | $-26.32M | $16.12M | $-15.75M | $-41.76M |
Shares Outstanding | 81.25M | 64.27M | 63.64M | 62.32M |